INDICATION
For active immunization against Measles Administered to children and adolescents who have been vaccinated before or have had measles infection earlier
ROUTE OF ADMINISTRATION
Subcutaneous injection
DOSE
In Developing countries : At 9 months of AgeIn industrialized countries: At 12 -15 months of Age
COMPOSITION
Each single human dose when reconstituted in a volume of 0.5ml contains not less than 1000 CCID50 of live Measles virus particles.
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
